Bhattacharya S P, Anyaibe S I, Headings V E
Br J Haematol. 1976 Jul;33(3):401-8. doi: 10.1111/j.1365-2141.1976.tb03557.x.
The development of highly specific fluorescent labelled antibodies against haemoglobin F presented an opportunity to investigate variables which might influence distribution of this haemoglobin among individual erythrocytes. Earlier investigations revealed heterogeneous distribution within healthy individuals and in individuals with sickle cell disease and other haemoglobinopathies. The current study demonstrates quantitatively that there are normal biological determinants of variability in the frequency of F-containing erythrocytes in individuals who have a haemoglobin A electrophoretic phenotype. It also is shown that the frequency of F-containing erythrocytes during the early recovery phase of sickle cell crisis is significantly higher than when there is no recent history of crisis. The mean quantity of ahemoglobin F per F-containing erythrocyte appears to be lower after a crisis than in individuals without recent history of crisis. This suggests that following a crisis there may either be biochemical constraints on haemoglobin F synthesis per erythrocyte precursor cell or else there is limited opportunity for selective removal of low F-containing erythrocytes from the circulation.
针对血红蛋白F的高特异性荧光标记抗体的研发为研究可能影响该血红蛋白在单个红细胞中分布的变量提供了契机。早期研究揭示了健康个体以及镰状细胞病和其他血红蛋白病患者体内存在异质性分布。当前研究定量表明,具有血红蛋白A电泳表型的个体中,含F红细胞频率的变异性存在正常的生物学决定因素。研究还表明,镰状细胞危象早期恢复阶段含F红细胞的频率显著高于近期无危象病史时。危机过后,每个含F红细胞中血红蛋白F的平均含量似乎低于近期无危机病史的个体。这表明危机过后,每个红细胞前体细胞在血红蛋白F合成方面可能存在生化限制,或者从循环中选择性清除低F含量红细胞的机会有限。